Skip to main content
Log in

Ziconotide worth it for zapping chronic pain in the UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Dewilde S, Verdian L, MacLaine GDH.Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK. Current Medical Research and Opinion 25: 2007-2019, No. 8, Aug 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziconotide worth it for zapping chronic pain in the UK. Pharmacoecon. Outcomes News 588, 10 (2009). https://doi.org/10.2165/00151234-200905880-00025

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00025

Keywords

Navigation